Last updated on October 2018

Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

Brief description of study

This registry will be used to identify patients who have etiology diagnosed or suspected to be Alzheimer's disease and positive amyloid scans, and have indicated their interest in being contacted for an Eli Lilly and Company (Lilly) Alzheimer's Disease drug research trial.

Clinical Study Identifier: NCT02918539

Contact Investigators or Research Sites near you

Start Over

Robert Falcone

Amici Clinical Research
Martinsville, NJ United States